XORTX Therapeutics Inc (XRTX) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.319x

Based on the latest financial reports, XORTX Therapeutics Inc (XRTX) has a cash flow conversion efficiency ratio of -0.319x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-629.62K ≈ $-455.46K USD) by net assets (CA$1.97 Million ≈ $1.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See XRTX net asset quality score to measure how much of total assets are equity-financed.

XORTX Therapeutics Inc - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how XORTX Therapeutics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check XORTX Therapeutics Inc (XRTX) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

XORTX Therapeutics Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of XORTX Therapeutics Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Olympio Metals Ltd AU:OLY	-2.352x
Maxeon Solar Technologies Ltd NASDAQ:MAXN	0.148x
Cerillion PLC LSE:CER	0.027x
Thai Setakij Insurance PCL BK:TSI	-0.190x
Realites PA:ALREA	-0.231x
Mamba Exploration Ltd AU:M24	-0.144x
Seya Industries Limited NSE:SEYAIND	-0.011x
BELLUSCURA PLC LS -01 F:9VQ	N/A

Annual Cash Flow Conversion Efficiency for XORTX Therapeutics Inc (2018–2024)

The table below shows the annual cash flow conversion efficiency of XORTX Therapeutics Inc from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see XORTX Therapeutics Inc stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$3.34 Million ≈ $2.41 Million	CA$-3.68 Million ≈ $-2.66 Million	-1.103x	+22.26%
2023-12-31	CA$4.64 Million ≈ $3.36 Million	CA$-6.58 Million ≈ $-4.76 Million	-1.418x	+17.35%
2022-12-31	CA$6.97 Million ≈ $5.05 Million	CA$-11.97 Million ≈ $-8.66 Million	-1.716x	-373.73%
2021-12-31	CA$16.74 Million ≈ $12.11 Million	CA$-6.06 Million ≈ $-4.39 Million	-0.362x	+37.53%
2020-12-31	CA$1.26 Million ≈ $908.75K	CA$-728.40K ≈ $-526.91K	-0.580x	-149.19%
2019-12-31	CA$-211.72K ≈ $-153.16K	CA$-249.58K ≈ $-180.54K	1.179x	+124.37%
2018-12-31	CA$321.54K ≈ $232.60K	CA$-1.56 Million ≈ $-1.13 Million	-4.837x	--

About XORTX Therapeutics Inc

V:XRTX Canada Biotechnology

Market Cap

$14.30 Million

CA$19.77 Million CAD

Market Cap Rank

#29147 Global

#1347 in Canada

Share Price

CA$2.84

Change (1 day)

-3.73%

52-Week Range

CA$0.49 - CA$3.96

All Time High

CA$387.99